Side-by-side comparison of AI visibility scores, market position, and capabilities
Greenhouse salad greens brand acquired by Cox Enterprises; operates regional greenhouse hubs near major US markets for same-day freshness.
BrightFarms is a New York-based greenhouse farming and food brand founded in 2011 by Paul Lightfoot. The company builds and operates greenhouse facilities near major metropolitan areas across the US, producing packaged salad greens, herbs, and tomatoes for retail grocery partners. In August 2021, BrightFarms was acquired by Cox Enterprises, the Atlanta-based private conglomerate, providing significant capital for expansion.\n\nBrightFarms operates regional greenhouse hubs strategically located within hours of major retail distribution centers, enabling next-day delivery from farm to store shelf — a freshness advantage over field-grown competitors shipped thousands of miles from California or Mexico. Its products are sold under the BrightFarms brand and co-branded store labels at grocery chains including Walmart, Giant Food, and regional supermarkets.\n\nThe company's model prioritizes proximity and regional density over national vertical farming scale-up, allowing it to maintain supply chain resilience and consistent product quality. As part of Cox Enterprises, BrightFarms has access to patient capital and strategic support without pressure to achieve rapid unicorn-scale growth, making it one of the most sustainably positioned players in the US controlled environment agriculture sector.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.